Smartphone Magnetometer Uses Magnetized Hydrogel to Measure Biomarkers for Disease Diagnosis
By HospiMedica International staff writers Posted on 03 Apr 2024 |

Almost every modern smartphone incorporates a compass or magnetometer, which senses Earth's magnetic field, crucial for navigation purposes. Now, a newly developed technique uses an ordinary cellphone magnetometer to precisely measure glucose levels, an important diabetes indicator. This approach, combined with magnetic materials that change their shape in reaction to biological or environmental stimuli, can be employed to assess a wide array of biomedical properties crucial for human disease monitoring or diagnosis, as well as detecting environmental pollutants.
In their proof-of-concept study, a team of researchers at the National Institute of Standards and Technology (NIST, Gaithersburg, MD, USA) attached a tiny well filled with the test solution and a hydrogel strip, to a smartphone. This hydrogel, a porous material that swells when immersed in water, was embedded with tiny magnetic particles engineered to respond to glucose presence or pH changes by swelling or contracting. Changing pH levels is associated with various biological disorders. When the hydrogels enlarged or shrank, they forced the magnetic particles to come closer to or go farther from the cellphone’s magnetometer, which detected the corresponding changes in the strength of the magnetic field. Utilizing this innovative approach, the team succeeded in measuring glucose concentrations as small as a few millionths of a mole levels. Although such high sensitivity is not needed for home glucose monitoring using blood tests, it could pave the way for saliva-based glucose testing, where sugar concentration is notably lower.
The method's simplicity, without the need for any additional electronics or power sources except for the smartphone or requirement for sample processing, presents an economical solution for widespread testing, even in resource-limited areas. Future potential improvements in measuring accuracy through smartphone magnetometers could lead to detection of DNA, specific proteins, and histamines — key immune response elements — at extremely low concentrations. For example, accurately measuring histamines, typically found in urine at concentrations ranging from about 45 to 190 nanomoles, would usually require a 24-hour urine collection and complex lab analyses. Similarly, the team found that a cellphone magnetometer can measure pH levels with sensitivity equal to a thousand-dollar benchtop meter but at a substantially lower cost. To make smartphone-based measurements a market success, engineers will have to devise a mass-production strategy for the hydrogel test strips and ensure their long shelf life.
Related Links:
NIST
Latest Critical Care News
- Breakthrough Sensor Technology Tracks Stroke After Effects
- New Study Demonstrates AI-Assisted Detection of Reduced Ejection Fraction
- Novel 3D Adipose Tissue Bioprinting Method to Find Applications in Regenerative Medicine
- Miniaturized Pacemaker for Newborns Found Safe and Effective for Up to Two Years
- World’s First 3D Neural Electrode Uses Soft Actuation Technology to Avoid Nerve Damage
- Smartwatch Algorithm Detects Cardiac Arrest
- Blood-Brain Barrier “Organ Chip” Treats Brain Tumors Unreachable by Chemotherapy
- AI Model Could Use ECG Tests to Detect Premature Aging and Cognitive Decline
- World-First Technology Uses Real-Time ECG Signal Analysis for Accurate CVAD Placement
- AI Outperforms Humans at Analyzing Long-Term ECG Recordings
- Smart Sensor Enables Precise, Self-Powered Tracking of Healing Wounds
- Skin Patch Activates New Gene Switch to Treat Diabetes
- Zinc-Based Dissolvable Implants to Transform Bone Repair
- Self-Healing Electronic Skin Repairs Itself in Seconds After Damage
- Light-Activated ‘Smart Bomb’ Advances Breast Cancer Treatment
- New Implant to Help Patients Regenerate Their Own Heart Valves
Channels
Artificial Intelligence
view channel
Innovative Risk Score Predicts Heart Attack or Stroke in Kidney Transplant Candidates
Heart researchers have utilized an innovative risk assessment score to accurately predict whether patients being evaluated for kidney transplants are at risk for future major cardiac events, such as a... Read more
AI Algorithm Detects Early-Stage Metabolic-Associated Steatotic Liver Disease Using EHRs
Liver disease, which is treatable when detected early, often goes unnoticed until it reaches advanced stages. Metabolic-associated steatotic liver disease (MASLD), the most prevalent form of liver disease,... Read moreSurgical Techniques
view channel
Screw-Shaped Magnetic Microrobots to Transform Treatment for Patients with Inoperable Blood Clots
Cardiovascular conditions such as thrombosis pose a significant global health issue, with blood clots being responsible for one in four deaths worldwide each year. A blood clot can obstruct a blood vessel,... Read more
"Ultra-Rapid" Testing in the OR Could Enable Accurate Removal of Brain Tumors
For many cancers, including brain tumors, the success of surgery and the prevention of cancer recurrence depend on removing as much of the tumor and surrounding cancerous cells as safely as possible.... Read morePatient Care
view channel
Portable Biosensor Platform to Reduce Hospital-Acquired Infections
Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds
Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more
Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization
An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more
Game-Changing Innovation in Surgical Instrument Sterilization Significantly Improves OR Throughput
A groundbreaking innovation enables hospitals to significantly improve instrument processing time and throughput in operating rooms (ORs) and sterile processing departments. Turbett Surgical, Inc.... Read moreHealth IT
view channel
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read more
Smartwatches Could Detect Congestive Heart Failure
Diagnosing congestive heart failure (CHF) typically requires expensive and time-consuming imaging techniques like echocardiography, also known as cardiac ultrasound. Previously, detecting CHF by analyzing... Read morePoint of Care
view channel
Handheld, Sound-Based Diagnostic System Delivers Bedside Blood Test Results in An Hour
Patients who go to a doctor for a blood test often have to contend with a needle and syringe, followed by a long wait—sometimes hours or even days—for lab results. Scientists have been working hard to... Read more
Smartphone-Enabled, Paper-Based Quantitative Diagnostic Platform Transforms POC Testing
Point-of-care diagnostics are crucial for public health, offering rapid, on-site testing that enables prompt diagnosis and treatment. This is especially valuable in remote or underserved regions where... Read moreBusiness
view channel
Boston Scientific Acquires Medical Device Company SoniVie
Boston Scientific Corporation (Marlborough, MA, USA) has entered into a definitive agreement to acquire SoniVie Ltd. (Rehovot, Israel), the developer of the TIVUS Intravascular Ultrasound System.... Read more
2026 World Hospital Congress to be Held in Seoul
The International Hospital Federation (IHF, Bernex, Switzerland) has announced that the 49th World Hospital Congress will be held in Seoul, Republic of Korea, in October 2026 with the Korean Hospital Association... Read more
Teleflex to Acquire BIOTRONIK’s Vascular Intervention Business
Teleflex (Wayne, PA, USA) has entered into a definitive agreement to acquire substantially all of the Vascular Intervention business of BIOTRONIK (Berlin, Germany) for an estimated cash payment on closing... Read more